Valuation : BioHarvest Sciences Inc.

Market Cap 4.17Cr 3.59Cr 3.37Cr 3.08Cr 5.79Cr 398.63Cr 5.81Cr 40Cr 16Cr 201.23Cr 16Cr 15Cr 667.23Cr P/E 2026 *
-3.49x
P/E 2027 * -5.49x
Enterprise Value 4.17Cr 3.59Cr 3.37Cr 3.08Cr 5.79Cr 398.63Cr 5.81Cr 40Cr 16Cr 201.23Cr 16Cr 15Cr 667.23Cr EV / Sales 2026 *
1.11x
EV / Sales 2027 * 0.84x
Free-Float
85.23%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 68 29/04/2026
Director of Finance/CFO - 28/10/2024
Chief Operating Officer 65 19/04/2023
Director TitleAgeSince
Chairman 68 27/09/2018
Director/Board Member 67 27/09/2018
Director/Board Member 84 07/02/2019
Change 5-day change 1-year change 3-year change Capi.($)
+6.06%-2.94% - - 4.17Cr
+0.02%+1.36%-13.16%-6.82% 1.33TCr
+0.53%+2.99%-31.39%-57.20% 499.01Cr
+0.27%+1.59%-5.32%-1.35% 465.93Cr
-0.43%-1.64%-1.22%-30.41% 401.78Cr
+0.08%+3.06%-20.99%+4.99% 359.48Cr
-0.67%+2.71%-2.98%-5.08% 343.15Cr
+0.47%-0.53%-9.87%+6.74% 330.63Cr
-2.19%-2.26%-22.25%-14.00% 237.78Cr
+0.74%+2.97%-26.78%-13.38% 172.3Cr
Average +0.49%+1.90%-14.88%-12.95% 459.56Cr
Weighted average by Cap. -0.04%+1.73%-13.98%-13.01%

Financials

2026 *2027 *
Net sales 3.74Cr 3.22Cr 3.02Cr 2.76Cr 5.2Cr 357.63Cr 5.22Cr 36Cr 14Cr 180.53Cr 14Cr 14Cr 598.6Cr 4.96Cr 4.27Cr 4.01Cr 3.66Cr 6.89Cr 473.96Cr 6.91Cr 48Cr 19Cr 239.25Cr 19Cr 18Cr 793.31Cr
Net income -1.2Cr -1.04Cr -97.11L -88.64L -1.67Cr -114.87Cr -1.68Cr -12Cr -4.49Cr -58Cr -4.51Cr -4.41Cr -192.27Cr -76.48L -65.9L -61.79L -56.41L -1.06Cr -73Cr -1.07Cr -7.33Cr -2.86Cr -37Cr -2.87Cr -2.81Cr -122.35Cr
Net Debt - -
Logo BioHarvest Sciences Inc.
BioHarvest Sciences Inc. is a Canada-based botanical synthesis company. The Company leverages its technology platform to grow plant-based compounds, without the need to grow the underlying plant. It is leveraging its botanical synthesis technology to develop science-based therapeutic solutions within two major business verticals; as a contract development and manufacturing organization (CDMO) on behalf of customers seeking plant-based compounds, and as a creator of nutraceutical health and wellness products, which include dietary supplements. It delivers phytochemicals such as age-defying antioxidants and polyphenols used for wellness. Its product pipeline is focused on polyphenols, which include grape cells, olive cells, and pomegranate cells. Its process involves selecting the specific plant cells that can create the targeted ingredients. It offers VINIA, which is a nutraceutical containing the entire matrix of polyphenols contained in red grapes, including Piceid resveratrol.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.840USD
Average target price
10.50USD
Spread / Average Target
+470.65%

Quarterly revenue - Rate of surprise